Polyplus, a leading provider of research through commercial grade upstream process solutions for advanced biologic and cell and gene therapy production, today announces it is investing in new …
( read original story …)
The Shanghai News
Polyplus, a leading provider of research through commercial grade upstream process solutions for advanced biologic and cell and gene therapy production, today announces it is investing in new …
( read original story …)